| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &Chief Commercial Officer
1 company
Dreyer Scott serves as an EVP &Chief Commercial Officer at COLL. Across recent SEC filings that breaks down to 0 buys and 31 sells. Those positions are worth an estimated $2.9M at current prices.
Historically, Dreyer Scott's trades have earned a middling insider score of 54/100 across 16 rated trades. Over a 12-month horizon, 23.1% of those trades were profitable, with an average 12-month return of -12.0%.
The biggest single holding is COLL (~$2.9M) as EVP &Chief Commercial Officer. The recent filings there lean toward selling, a net 349,166 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | COLL Collegium Pharmaceutical, Inc. | EVP &Chief Commercial Officer | Sell10b5-1 | 49,976 | $40.41 | $2,019,436.72 | -41.0% | -20.6% | - | |
| Dec 8, 2025 | COLL Collegium Pharmaceutical, Inc | EVP &Chief Commercial Officer | Sale+OE10b5-1 | 17,600 | $48.17 | $847,855.20 | -14.5% | -22.2% | - | |
| Aug 18, 2025 | COLL Collegium Pharmaceutical, Inc | EVP &Chief Commercial Officer | Sale+OE10b5-1 | 16,389 | $38.21 | $626,171.25 | -13.7% | +18.7% | -25.4% | |
| Aug 13, 2025 | COLL Collegium Pharmaceutical, Inc | EVP &Chief Commercial Officer | Sale+OE10b5-1 | 4,861 | $38.03 | $184,880.84 | -4.5% | +18.4% | -25.6% | |
| Mar 21, 2025 | COLL Collegium Pharmaceutical, Inc | EVP &Chief Commercial Officer | Sell10b5-1 | 20,808 | $30.03 | $624,794.18 | -16.7% | -0.7% | +17.9% | |
| Mar 14, 2025 | COLL Collegium Pharmaceutical, Inc | EVP &Chief Commercial Officer | Sell10b5-1 | 2,255 | $30.00 | $67,661.05 | -1.8% | +0.5% | +17.1% | |
| Mar 7, 2025 | COLL Collegium Pharmaceutical, Inc | EVP &Chief Commercial Officer | Sell10b5-1 | 5,643 | $30.00 | $169,299.49 | -3.8% | +2.0% | +28.9% | |
| Mar 6, 2025 | COLL Collegium Pharmaceutical, Inc | EVP &Chief Commercial Officer | Sell10b5-1 | 15,387 | $30.00 | $461,671.55 | -10.8% | -1.3% | +25.0% | |
| May 24, 2024 | COLL Collegium Pharmaceutical, Inc | EVP &Chief Commercial Officer | Sale+OE | 108,016 | $33.91 | $3,662,548.45 | -50.5% | +5.2% | -15.7% | |
| Feb 26, 2024 | COLL Collegium Pharmaceutical, Inc | EVP &Chief Commercial Officer | Sell10b5-1 | 10,000 | $36.43 | $364,270.33 | -6.7% | -6.0% | -21.2% |